Loxoprofen Impurity 18, with the CAS number 99807-54-2, is a chemical compound that is recognized as an impurity associated with the pharmaceutical drug loxoprofen, a non-steroidal anti-inflammatory drug (NSAID). While specific details about Loxoprofen Impurity 18 may not be extensively documented, impurities in pharmaceuticals typically arise during the synthesis or degradation of the active pharmaceutical ingredient. Such impurities can affect the drug's efficacy, safety, and stability. Generally, impurities are characterized by their molecular structure, which may include functional groups that can influence their reactivity and interactions. The presence of impurities like Loxoprofen Impurity 18 is monitored through quality control measures in pharmaceutical manufacturing to ensure compliance with regulatory standards. Understanding the characteristics of such impurities is crucial for assessing their potential impact on drug formulation and patient safety. Further studies may be required to elucidate its specific chemical properties, biological activity, and toxicological profile.

Loxoprofen Impurity 18

99807-54-2: Loxoprofen Impurity 18, with the CAS number 99807-54-2, is a chemical compound that is recognized as an impurity associated with the pharmaceutical drug loxoprofen, a non-steroidal anti-inflammatory drug (NSAID). While specific details about Loxoprofen Impurity 18 may not be extensively documented, impurities in pharmaceuticals typically arise during the synthesis or degradation of the active pharmaceutical ingredient. Such impurities can affect the drug's efficacy, safety, and stability. Generally, impurities are characterized by their molecular structure, which may include functional groups that can influence their reactivity and interactions. The presence of impurities like Loxoprofen Impurity 18 is monitored through quality control measures in pharmaceutical manufacturing to ensure compliance with regulatory standards. Understanding the characteristics of such impurities is crucial for assessing their potential impact on drug formulation and patient safety. Further studies may be required to elucidate its specific chemical properties, biological activity, and toxicological profile.

CAS 99807-54-2

Loxoprofen Impurity 18

Loxoprofen Impurity 9

Ref: 4Z-L-8932

4-(Bromomethyl)-α-methyl-benzeneacetic Acid Methyl Ester

Ref: TR-B890440